The dual strategy of inhibiting the viral life cycle and reducing the host inflammatory response should be considered in the development of therapeutic drugs for influenza A virus (IAV). In this study, an extract of Scutellaria baicalinase (SBE) containing seven flavonoids was identified to exert both antiviral and anti-inflammatory effects in macrophages infected with IAV. We performed transcriptome analysis using high-throughput RNA sequencing and identified 315 genes whose transcription levels were increased after IAV infection but were able to be decreased after SBE intervention. Combined with Gene Ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis, these genes were mainly involved in TLR3/7/8, RIG-I/MDA5, NLRP3 and cGAS pattern recognition receptor (PRR)-mediated signaling pathways. SBE inhibited the transcription of essential genes in the above pathways and nuclear translocation of NF-κB p65 as confirmed by RT-qPCR and immunofluorescence, respectively, indicating that SBE reversed PR8-induced over-activation of the PRR signaling pathway and inflammation in macrophages. This study provides an experimental basis for applying Scutellaria baicalensis and its main effects in the clinical treatment of viral pneumonia. It also provides novel targets for screening and developing novel drugs to prevent and treat IAV infectious diseases.
24 June 2024 in Chinese Journal of Integrative Medicine
Background: Uterine corpus endometrial carcinoma (UCEC) ranks as a predominant tumor within the female reproductive system. Matrine, the chief active constituent of Compound Kushen Injection, exhibits antibacterial, antiviral, anti‐inflammatory, and antitumor effects. On the basis of previous research studies, this study utilized bioinformatics and network pharmacology approaches to investigate matrine’s anti‐UCEC potential, establishing a theoretical groundwork for subsequent mechanistic studies.Objective: Differentially expressed genes (DEGs) from the TCGA‐UCEC database were processed using R packages. Potential targets of matrine were identified via PubChem, SwissTargetPrediction, and BindingDB. The hub genes were identified through cytoHubba from the overlapping genes of matrine targets and UCEC DEGs. These genes were then subjected to cancer immune infiltration analysis, assessed with the R package “ggbeeswarm,” and validated by molecular docking studies.Results: We identified 28 potential drug–disease interaction genes and narrowed down to 10 hub genes. Notably, CDH1 and EPCAM were significantly differentially expressed between tumor and normal samples. Their expression levels correlated positively with multiple immune cells types. Molecular docking revealed significant interactions between CDH1, EPCAM, and matrine.Conclusions: These findings suggest that matrine’s anti‐UCEC activity may involve interactions with CDH1 and EPCAM. Advancing UCEC therapy based on these interactions could improve tumor diagnosis and treatment, including for UCEC.